1. Home
  2. BNTC vs ALLT Comparison

BNTC vs ALLT Comparison

Compare BNTC & ALLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • ALLT
  • Stock Information
  • Founded
  • BNTC 1995
  • ALLT 1996
  • Country
  • BNTC United States
  • ALLT Israel
  • Employees
  • BNTC N/A
  • ALLT N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • ALLT Telecommunications Equipment
  • Sector
  • BNTC Health Care
  • ALLT Telecommunications
  • Exchange
  • BNTC Nasdaq
  • ALLT Nasdaq
  • Market Cap
  • BNTC 365.1M
  • ALLT 342.5M
  • IPO Year
  • BNTC N/A
  • ALLT 2006
  • Fundamental
  • Price
  • BNTC $13.90
  • ALLT $10.85
  • Analyst Decision
  • BNTC Strong Buy
  • ALLT Buy
  • Analyst Count
  • BNTC 5
  • ALLT 1
  • Target Price
  • BNTC $24.80
  • ALLT N/A
  • AVG Volume (30 Days)
  • BNTC 40.3K
  • ALLT 489.2K
  • Earning Date
  • BNTC 11-13-2025
  • ALLT 11-18-2025
  • Dividend Yield
  • BNTC N/A
  • ALLT N/A
  • EPS Growth
  • BNTC N/A
  • ALLT N/A
  • EPS
  • BNTC N/A
  • ALLT N/A
  • Revenue
  • BNTC N/A
  • ALLT $95,342,000.00
  • Revenue This Year
  • BNTC N/A
  • ALLT $10.64
  • Revenue Next Year
  • BNTC N/A
  • ALLT $15.76
  • P/E Ratio
  • BNTC N/A
  • ALLT N/A
  • Revenue Growth
  • BNTC N/A
  • ALLT 4.74
  • 52 Week Low
  • BNTC $9.09
  • ALLT $2.78
  • 52 Week High
  • BNTC $17.15
  • ALLT $11.42
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 54.74
  • ALLT 66.22
  • Support Level
  • BNTC $13.49
  • ALLT $9.55
  • Resistance Level
  • BNTC $14.01
  • ALLT $11.41
  • Average True Range (ATR)
  • BNTC 0.54
  • ALLT 0.52
  • MACD
  • BNTC -0.04
  • ALLT 0.07
  • Stochastic Oscillator
  • BNTC 64.70
  • ALLT 74.02

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About ALLT Allot Ltd.

Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. The company has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.

Share on Social Networks: